Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes

Journal of Cellular Biochemistry

Volumn 104, Issue 2, 2008, Pages 391-401

  Wen, Yu ^a   Wang, HongWei ^b   MacLaren, Robin ^b,c   Wu, Jing ^a   Lu, HuiLing ^b   Cianflone, Katherine ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b LAVAL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

C3adesArg; C5L2; G protein coupled receptor; Glucose transport; Insulin; Intracellular signalling

Indexed keywords

ACYLATION STIMULATING PROTEIN; FATTY ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; OLEIC ACID; PALMITIC ACID; PROTEIN KINASE;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CELL STRAIN 3T3; CELL SURFACE; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INCUBATION TIME; INSULIN RESISTANCE; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROADIPOCYTE;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; COMPLEMENT C3; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; MICE; OLEIC ACID; PALMITATES; RECEPTORS, CHEMOKINE;

EID: 43449136184     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21631     Document Type: Article

References (53)

1. Baldo A, Sniderman AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, Cianflone K. 1993. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 92:1543-1547.
2. Baldo A, Sniderman AD, St.Luce S, Zhang XJ, Cianflone K. 1995. Signal transduction pathway of acylation stimulating protein: Involvement of protein kinase C. J Lipid Res 36:1415-1426.
3. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. 2006. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4-12.
4. Cianflone K, Xia Z, Chen LY. 2003. Critical review of acylation stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609:127-143.
5. Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman AD. 2004. Fasting acylation stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res 45:124-131.
6. Cornwell DG, Kruger KS, Hamwi GJ, Brown JB. 1962. Correlations between lipoprotein concentration and fatty acid composition in serum of normal and hyperlipemic subjects: A review. Metabolism 11:840-849.
7. Dyck DJ, Heigenhauser GJ, Bruce CR. 2006. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 186:5-16.
8. Faraj M, Cianflone K 2004a. Differential regulation of fatty acid trapping in mice adipose tissue and muscle by ASP. Am J Physiol 287:E150-E159.
9. Faraj M, Sniderman AD, Cianflone K. 2004b. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J Lipid Res 45:657-666.
10. Fasshauer M, Paschke R, Stumvoll M. 2004. Adiponectin, obesity, and cardiovascular disease. Biochimie 86:779-784.
11. Frayn KN. 2005. Obesity and metabolic disease: is adipose tissue the culprit? Proc Nutr Soc 64:7-13.
12. Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, Ye J. 2004. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol 18:2024-2034.
13. Germinario R, Sniderman AD, Manuel S, Pratt S, Baldo A, Cianflone K. 1993. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation stimulating protein. Metabolism 42:574-580.
14. Hodgkinson CP, Mander A, Sale GJ. 2005. Identification of 80K-H as a protein involved in GLUT4 vesicle trafficking. Biochem J 388:785-793.
15. Imamura T, Huang J, Dalle S, Ugi S, Usui I, Luttrell LM, Miller WE, Lefkowitz RJ, Olefsky JM. 2001. beta-Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem 276:43663-43667.
16. Kalant D, Phelis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD. 2000. Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. J Lipid Res 41:1963-1968.
17. Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN. 2003. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J Biol Chem 278:11123-11129.
18. Kalant D, Maclaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K. 2005. C5L2 is a functional receptor for acylation stimulating protein. J Biol Chem 280:23936-23944.
19. Kotani K, Ogawa W, Matsumoto M, Kitamura T, Sakaue H, Hino Y, Miyake K, Sano W, Akimoto K, Ohno S, Kasuga M. 1998. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol 18:6971-6982.
20. Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. 2003. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: Prevention by rosiglitazone. Biochem Biophys Res Commun 311:372-379.
21. Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J, Caron M. 2006. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia 49:2162-2173.
22. Liu LZ, He AB, Liu XJ, Li Y, Chang YS, Fang FD. 2006. Protein kinase Czeta and glucose uptake. Biochemistry (Mosc) 71:701-706.
23. MacLaren R, Kalant D, Cianflone K. 2007. The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem Cell Biol 85:11-21.
24. Marcil M, Vu H, Cui W, Dastani Z, Engert JC, Gaudet D, Castro-Cabezas M, Sniderman AD, Genest J, Jr., Cianflone K. 2006. Identification of a novel C512 variant (S323i) in a french Canadian family. Arterio Thromb Vasc Biol 26:1619-1925.
25. Maslowska M, Sniderman AD, Germinario R, Cianflone K. 1997. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes Relat Metab Disord 21: 261-266.
26. Maslowska M, Wang HW, Cianflone K. 2005. Novel roles for acylation stimulating protein/C3adesArg: A review of recent in vitro and in vivo evidence. Vitam Horm 70:309-332.
27. Maslowska M, Legakis H, Assadi F, Cianflone K. 2006. Targeting the signaling pathway of acylation stimulating protein. J Lipid Res 47:643-652.
28. Munzberg H, Myers MG, Jr. 2005. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8:566-570.
29. Murray I, Parker RA, Kirchgessner TG, Tran J, Zhang ZJ, Westerlund J, Cianflone K. 1997. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin. J Lipid Res 38:2492-2501.
30. Murray I, Sniderman AD, Cianflone K. 1999a. Mice lacking acylation stimulating protein (ASP) have delayed post-prandial triglyceride clearance. J Lipid Res 40:1671-1676.
31. Murray I, Sniderman AD, Havel PJ, Cianflone K. 1999b. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem 274:36219-36225.
32. Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, Zalevsky J, Dahiyat BI, Chi NW, Olefsky JM. 2005. JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 280: 35361-35371.
33. Ogihara T, Asano T, Katagiri H, Sakoda H, Anai M, Shojima N, Ono H, Fujishiro M, Kushiyama A, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Gotoh Y, Komuro I, Fujita T. 2004. Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia 47:794-805.
34. Ohno M, Hirata T, Enomoto M, Araki T, Ishimaru H, Takahashi TA. 2000. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol 37:407-412.
35. Okinaga S, Slattery D, Humbles A, Zsengeller Z, Morteau O, Kinrade MB, Brodbeck RM, Krause JE, Choe HR, Gerard NP, Gerard C. 2003. C5L2, a non-signaling C5A binding protein. Biochemistry 42:9406-9415.
36. Oriente F, Andreozzi F, Romano C, Perruolo G, Perfetti A, Fiory F, Miele C, Beguinot F, Formisano P. 2005. Protein kinase C-alpha regulates insulin action and degradation by interacting with insulin receptor substrate-1 and 14-3-3 epsilon. J Biol Chem 280:40642-40649.
37. Ozata M, Ortenli C, Culec M, Ozgurtas T, Bulucu F, Caglar R, Bingol N, Vural A, Ozdemir C. 2002. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome. J Clin Endocrinol Metab 87:853-858.
38. Paglialunga S, Schrauwen P, Moonen-Kornips E, Lu HL, Hesselink MKC, Cianflone K. 2007. Reduced adipose tissue triglyceride synthesis and delayed fatload clearance in C5L2 mice. J Endocrinol 194:293-304.
39. Permana PA, Menge C, Reaven PD. 2006. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 341: 507-514.
40. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. 2006. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 26:968-976.
41. Rachdaoui N, Nagy LE. 2003. Endothelin-1-stimulated glucose uptake is desensitized by tumor necrosis factor-alpha in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 285:E545-E551.
42. Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. 1998. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 39:884-891.
43. Scantlebury T, Maslowska M, Cianflone K. 1998. Chylomicron specific enhancement of acylation stimulating protein (ASP) and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 273: 20903-20909.
44. Scantlebury T, Sniderman AD, Cianflone K. 2001. Retinoic acid regulation of acylation stimulating protein (ASP) and complement C3 in human adipocytes. Biochem J 356:445-452.
45. Schrauwen P, Hesselink MKC, Jain M, Cianflone K. 2005. Acylation stimulating protein (ASP): Effect of acute exercise and endurance training. Intl J Obes (Lond) 29: 632-638.
46. Suganami T, Nishida J, Ogawa Y. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25:2062-2068.
47. Tagami S, Inokuchi Ji J, Kabayama K, Yoshimura H, Kitamura F, Uemura S, Ogawa C, Ishii A, Saito M, Ohtsuka Y, Sakaue S, Igarashi Y. 2002. Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem 277:3085-3092.
48. Tao Y, Cianflone K, Sniderman AD, Colby-Germinario SP, Germinario RJ. 1997. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim Biophys Acta 1344:221-229.
49. Van Epps-Fung M, Williford J, Wells A, Hardy RW. 1997. Fatty acid-induced insulin resistance in adipocytes. Endocrinology 138:4338-4345.
50. Xia Z, Sniderman AD, Cianflone K. 2002. Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 277:45874-45879.
51. Xia Z, Stanhope KL, Digitale E, Simion O-M, Chen LY, Havel PJ, Cianflone K. 2004. ASP deficiency results in increased energy expenditure in mice. J Biol Chem 279: 4051-4057.
52. Xie W, Hamilton JA, Kirkland JL, Corkey BE, Guo W. 2006. Oleate-induced formation of fat cells with impaired insulin sensitivity. Lipids 41:267-271.
53. Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K. 2006. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes 30:439-446.